Behind every enrollment milestone is a web of relationships—some strong, some strained, and some that make all the difference. At Rho, we don’t just talk about site engagement. We live […]
Successful NDA submissions require a foundational regulatory and clinical strategy that can adapt to the challenges and competing priorities of the drug development process and ultimately drive the program forward. Read our case study to learn more about the approaches and activities we implemented to meet timeline goals
Recruitment and enrollment are the backbone of a robust clinical trial. It’s not enough to meet the number of patients required to produce reliable data but critically important to recruit […]
A cutting-edge biotech was running a program with three active, concurrent, pain studies across 25 sites and 218 patients, with interim database locks scheduled during the summer of 2020 and […]
The COVID-19 pandemic created challenges and opportunities in the implementation of decentralized solutions. To fully realize all the advantages and benefits of a truly decentralized approach, partnering with a reliable […]
Over a three year period, Rho and Anthera Pharmaceuticals developed a collaborative partnership developing a product to treat Cystic Fibrosis. Some highlights of the partnership included: Expanding the scope of […]
© 2025 Rho, Inc. All rights reserved.
